Navigation Links
SCOLR Pharma, Inc. Reports Third Quarter 2010 Financial Results
Date:11/10/2010

BOTHELL, Wash., Nov. 10, 2010 /PRNewswire-FirstCall/ -- SCOLR Pharma, Inc. (NYSE AMEX: DDD) today reported financial results for the three and nine months ended September 30, 2010.Stephen J. Turner, SCOLR Pharma's President and CEO, said, "Our focus for the remainder of the year will be to continue executing the plans for our extended release nutritional supplement and drug delivery businesses, which have both been advanced in the last quarter.

"We believe that our extended release formulations of nutritional products will offer consumers the benefits of these supplements on a continuous basis throughout the day, while also providing retailers an opportunity to provide their customers with greater choice.  Working with the Emerson Group, we have been meeting with national retailers during their fourth quarter 2010 purchase planning cycles to present our nutritional products.  Orders placed by these retailers in late 2010 or early 2011 would be expected to ship in early-mid 2011," Turner added.

Turner continued:  "In the drug delivery business, we appear to be in the final stages of review by the Food and Drug Administration of our Abbreviated New Drug Application for extended release pseudoephedrine.  Additionally, we have nearly completed protocol planning for the actual use label comprehension study for our extended release, 12-hour ibuprofen product.  We expect to engage a services provider in the first quarter of 2011 in preparation for the conduct of that study. Additional revenue, financing or partnership support is required to complete the study, but we believe the Company is well positioned to move forward."

SCOLR Pharma also announced it was recently engaged by RedHill BioPharma, Ltd., to develop and test the manufacturing feasibility of prototype ondansetron tablets incorporating SCOLR's CDT technology. RedHill is an Isr
'/>"/>

SOURCE SCOLR Pharma, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. SCOLR Pharma, Inc. Names Carl Johnson as Chairman; Former Chairman Michael Taglich Remains as Director
2. SCOLR Pharma, Inc. Signs Agreement with The Emerson Group to Provide Sales Support for Nutritional & OTC Products
3. SCOLR Pharma, Inc. Enters into Worldwide Licensing Agreement with RedHill Biopharma Ltd.
4. SCOLR Pharma, Inc. Licenses Dietary Supplements
5. SCOLR Pharma, Inc. Receives Notices From NYSE Amex LLC Regarding Compliance Plan and Listing Standards
6. SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results
7. SCOLR Pharma, Inc. Reports Third Quarter 2008 Financial Results
8. SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen
9. Reportlinker Adds Merger and Acquisition Terms and Agreements in Pharma, Biotech and Diagnostics, 4th edition
10. Reportlinker Adds Co-promotion and Co-marketing Agreements in Pharma, Biotech and Diagnostics, 4th Edition
11. Horizon Pharma, Inc. Files Registration Statement for Proposed Initial Public Offering
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)... , March 31, 2015 Neurocrine Biosciences, Inc. ... entered into an exclusive collaboration and licensing agreement for ... in Japan and other select ... Mitsubishi Tanabe intends to initially develop NBI-98854 in ... Huntington,s disease and tardive dyskinesia. Neurocrine retains full commercial ...
(Date:3/31/2015)... UHC has released the findings of a new study ... cost and quality outcomes to uncover several trends related ... utilization of PPIs—which can account for 30% to 40% ... medical centers, focusing on procedures utilizing orthopedic implants, coronary ... The study, begun in 2013, integrated the pilot test ...
(Date:3/31/2015)... and ORANGEBURG, N.Y., March 31, 2015 /PRNewswire/ ...  VSCI) today announced the completion of their merger. ... and completion of the all-stock combination creates a ... Beginning on April 1, 2015, Cogentix Medical, Inc. ... CGNT. Cogentix Medical will have its U.S. headquarters ...
Breaking Medicine Technology:Neurocrine Biosciences and Mitsubishi Tanabe Pharma Announce Agreement to Develop and Commercialize VMAT2 Inhibitor NBI-98854 for Movement Disorders in Japan and Other Select Asian Markets 2Neurocrine Biosciences and Mitsubishi Tanabe Pharma Announce Agreement to Develop and Commercialize VMAT2 Inhibitor NBI-98854 for Movement Disorders in Japan and Other Select Asian Markets 3Neurocrine Biosciences and Mitsubishi Tanabe Pharma Announce Agreement to Develop and Commercialize VMAT2 Inhibitor NBI-98854 for Movement Disorders in Japan and Other Select Asian Markets 4UHC Study: Variations in Use of Physician Preference Items Affect Patient Outcomes and Costs 2UHC Study: Variations in Use of Physician Preference Items Affect Patient Outcomes and Costs 3Uroplasty and Vision-Sciences Complete Merger 2Uroplasty and Vision-Sciences Complete Merger 3Uroplasty and Vision-Sciences Complete Merger 4
... Mass., Nov. 16, 2011 Idenix Pharmaceuticals, Inc. (Nasdaq: ... and development of drugs for the treatment of human viral ... offering of 9,393,416 shares of its common stock at a ... shares are being sold by Idenix. The offering is expected ...
... YORK, Nov. 16, 2011 Reportlinker.com ... report is available in its catalogue: ... Cancer, Angiogenesis and Peptides ... This triple analysis focuses on cancer ...
Cached Medicine Technology:Idenix Pharmaceuticals Prices Public Offering of Common Stock 2Triple Analysis: Prostate Cancer, Angiogenesis and Peptides 2Triple Analysis: Prostate Cancer, Angiogenesis and Peptides 3Triple Analysis: Prostate Cancer, Angiogenesis and Peptides 4Triple Analysis: Prostate Cancer, Angiogenesis and Peptides 5
(Date:3/31/2015)... March 31, 2015 Due to ... to hire more caregivers, staffing personnel, and marketing ... care managers within the Greater Los Angeles area. ... institution, 1Heart Caregiver University has firmed up its ... mission to provide quality in-home care through a ...
(Date:3/31/2015)... York (PRWEB) April 01, 2015 Bon ... of Charity to the Schervier Nursing Care Center family ... of Mary the Queen in Yonkers which is scheduled ... Jane Iannucelli, SC, president of the Sisters of Charity ... Charity board of directors to place their Sisters at ...
(Date:3/31/2015)... Every day a new diet fad is introduced ... banned in other countries, and the diagnosis of American's ... & Natural Health Centers believe that by educating not ... reduce the future development of obesity and many other ... workshops at no charge in their clinics. Because yo-yo ...
(Date:3/31/2015)... On November 24, 2014, Per Wickstrom had ... discuss the problem of substance abuse and the solutions that ... drug abuse and recovery, gives a unique first-person perspective on ... teammates on the New York Giants, Taylor’s early career was ... tests, yet he was able to straighten out long enough ...
(Date:3/31/2015)... Chicago, IL (PRWEB) March 31, 2015 ... grow, Chunk Fitness is pledging to have a mobile-friendly ... 2015. This is part of Chunk Fitness’ continued commitment ... to its growing user base. All of the same ... be available; it will be substantially easier to read ...
Breaking Medicine News(10 mins):Health News:1Heart Ends 1st Quarter of the Year With 1Heart Caregiver University Training of New Staff and Commits To Provide More Jobs For Year 2015 2Health News:1Heart Ends 1st Quarter of the Year With 1Heart Caregiver University Training of New Staff and Commits To Provide More Jobs For Year 2015 3Health News:Bon Secours New York Health System Welcomes Retired Sisters of Charity to the Family 2Health News:Lawrence Taylor & Per Wickstrom Discuss the Drug Rehabilitation & Recovery Process 2
... can play an essential role in the most serious healthcare ... life care, according to research in the April issue of ... spent nearly 300 hours observing and carrying out interviews with ... a palliative care unit for people with terminal illnesses. ...
... Fla., April 8, 2008 Natural,Harmony Foods, Inc. (Pink Sheets: NHYF), announced today that it has,secured booth space at multiple ... Place ... June 5-7 Healthy Living Expo Dallas ... Chicago July 20-21 (To Be Confirmed) School ...
... Payment &, Coverage Policies Could Negatively Impact the ... ... Md., April 8, 2008 The National Coalition,for Quality Colorectal ... formation of a broad-based coalition dedicated,to reducing the incidence of ...
... day" Perhaps you should be. Adults who eat ... of metabolic syndrome, a cluster of health problems that are ... disease. , The study results, presented at the ... analysis of adult food consumption data collected in the 1999-2004 ...
... It,s common knowledge,that Americans suffer under a crushing ... the leading cause of death for men AND women. ... men and one in three,women will develop some type ... suggest that resveratrol and antioxidants could,literally be a silver ...
... My health manager proving to be the most actively-used ... 2008 Kaiser Permanente today,announced that more than 2 ... health manager, a number that shows that consumers find,Kaiser ... their,care., While many PHRs in the market are ...
Cached Medicine News:Health News:Humor plays an important role in healthcare even when patients are terminally ill 2Health News:Humor plays an important role in healthcare even when patients are terminally ill 3Health News:Natural Harmony Foods to Exhibit in Multiple Venues in '08 2Health News:Non-Profit Group Formed to Promote Safe Colorectal Cancer Screenings and Care: 2Health News:Non-Profit Group Formed to Promote Safe Colorectal Cancer Screenings and Care: 3Health News:Adults who eat apples, drink apple juice have lower risk for metabolic syndrome 2Health News:Dr. William S. Gruss, M.D., Says That Medical Research Shows You Can Reduce Your Risk of Cancer By Up To 77% and Reverse the Effects of Aging in A CARDIOLOGIST'S GUIDE TO ... ANTI-AGING, ANTIOXIDANTS & RESVERATROL 2Health News:Two Million People Using Kaiser Permanente's Personal Health Record 2
The upper body blanket is typically used for abdominal or lower body procedures. The upper body blankets warms the upper torso and arms. A clear drape is included to cover and warm the intubated pati...
Soft yet durable, these single-patient use pads are designed to have the quality look of reusable pads but provide the hygienic advantages of disposability....
This product is for the lower body and uses a Convective Warming System which is both soft and comfortable. Constructed of 2-ply material consisting of polyethylene film inner layer and non-woven out...
The torso blanket is designed to affix to the lower abdominal area and cover the upper half of the body....
Medicine Products: